Georgia CTSA COVID-19 Response
Georgia CTSA is taking an active role in monitoring the COVID-19 pandemic and sharing important news updates. We are continuously collecting and sharing news of how our trainees, scholars, investigators, faculty, and staff are responding to the COVID-19 virus. Learn more about what we are doing and resources available to you.
Funding Opportunities
NIH Funding Opportunities Specific to COVID-19
This page contains a listing of active funding opportunities specific to COVID-19.
COVID-19 Resources and Guidance: Information You Need, When and Where You Need It
View up-to-date NIH COVID-19 information including Informational Videos; Proposal Submission & Award Management Resources; Human Subjects & Clinical Trials Guidance; Animal Welfare; Frequently Asked Questions regarding flexibilities for grantees and Funding Opportunities.
Research Resources
N3C COVID-19 Analytics Platform
Researchers studying COVID-19 can access an innovative analytics platform that contains clinical data from the electronic health records of people who were tested for the novel coronavirus or who have had related symptoms. Part of the NCATS National COVID Cohort Collaborative (N3C) Data Enclave, the centralized and secure data platform features powerful analytics capabilities for online discovery, visualization and collaboration.
COVID-19 Collaboration Platform
The COVID-19 Collaboration Platform brings unassociated research teams working on the same clinical research questions together to share protocols, data, and evidence. COVID-19 Collaboration Platform offers support managing collaborations, including expedited and prioritized help from the Trial Innovation Network and SMART IRB to form multi-site trials; expert statistical advice for aggregated analyses, and free data storage and anonymization through vivli.org.
Community Resources
Participants Needed for COVID-19 Vaccine and Treatment Trials
All races and ethnicities are needed to participate in COVID-19 trials. Please spread the word to help recruit minorities, especially for vaccine trials. Register online.
Previous Events and Special Webinars
Blue Sky Groups
- Vaccine Development and Testing
- COVID-19 Vaccine Hesitancy
- Post-Acute Sequelae of SARS-CoV2
- COVID–19 and Cardiovascular Complications
- COVID-19 and Health Equity
- Brain Health and COVID 19: Part 1
- Brain Health and COVID 19: Part 2
Special COVID Webinars
- Managing Virtual Teams
- Community Engagement in the Era of COVID-19: Opportunities, Challenges, and Lessons Being Learned
- Managing Lab Trainees During this Unprecedented Time
- Managing Clinical Trainees During This Time
- Ramping Down Clinical Trials
Featured News
- Georgia CTSA Clinical Research Centers Director Recognized for Achievements During COVID-19 and Beyond
- Georgia CTSA Leaders Receive Nearly $20M NIH Grant as Part of Long COVID Nationwide Study
- ‘What’s Your Why?’ Georgia CEAL Ad Campaign to Reduce COVID-19 Vaccine Hesitancy
- Researchers Awarded NIH Grant to Conduct COVID-19 Surveillance Through Detection of SARS CoV-2 in Wastewater
- Vital Role of RADx Tech Team in Expediting Evaluations of COVID-19 Testing Devices
- Georgia CTSA Recruitment Center Helps Research Team Attain Goals for COVID-19 Pandemic Impact Survey
- GCRCs Staff Help Emory Healthcare Administer COVID-19 Vaccine to Over 100,000 People in Georgia
- Georgia CTSA Investigators Release Viewpoint on Long-term Health Consequences of COVID-19
- Georgia CTSA Leaders Provide Recommendations for Community Engagement of African Americans in COVID-19 Era
- Georgia CTSA Leader Explores Lack of Diversity in COVID-19 Trials
- Georgia CTSA Leader Discusses Importance of COVID-19 Trials on NPR Affiliate
- Outstanding Results from Phase 3 COVID-19 Vaccine Trial Led by Former Georgia CTSA KL2 Scholar
- Georgia CTSA Leader Heads NIH’s Georgia CEAL to Address COVID-19 Disparities
- Community Engagement Alliance (CEAL) Against COVID-19 Disparities
- NIH Delivering New COVID-19 Tests Validated by Georgia CTSA Leaders
- Georgia CTSA Leads Serosurvey for CDC and FEMA COVID-19 Responders
- Georgia CTSA Investigators Encouraged by COVID-19 Vaccine Trial
- NIH Launches National COVID Cohort Collaborative (N3C)
- Georgia CTSA Leaders to Begin Phase 1 Validation for National COVID-19 Tests
- Former Georgia CTSA KL2 Scholar Helps Lead COVID-19 Research Efforts
- Georgia CTSA CPTR Graduate's Anti-Inflammatory Drug Selected for International Phase 3 COVID-19 Trial
- COVID-19 Prevention Measures Advocated by Georgia CTSA MSCR Grad
- Georgia CTSA MSCR Grad Helps Develop Best Practices for COVID ICU
- Georgia CTSA Former Trainee Scales Up In-House COVID-19 Test
- Former Georgia CTSA Trainee Helps Lead ICU Response to COVID-19
- Georgia CTSA MSCR Graduates on Front Line of COVID-19 Battle
- Georgia CTSA Rapid Response Team Coordinates 48-Hour Approval for Treatment of Coronavirus Patient
- Georgia CTSA Leader Named to Georgia's Coronavirus Task Force